GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $634,000 | +62.1% | 16,598 | +51.6% | 0.06% | +100.0% |
Q1 2021 | $391,000 | -60.5% | 10,945 | -59.3% | 0.03% | -73.8% |
Q4 2020 | $989,000 | -23.2% | 26,867 | -21.5% | 0.11% | -51.6% |
Q3 2020 | $1,288,000 | +85.6% | 34,211 | +131.5% | 0.22% | +229.9% |
Q4 2019 | $694,000 | +207.1% | 14,781 | +161.8% | 0.07% | +415.4% |
Q2 2019 | $226,000 | -59.6% | 5,645 | -57.8% | 0.01% | -59.4% |
Q1 2019 | $559,000 | -9.3% | 13,383 | -17.0% | 0.03% | -3.0% |
Q4 2018 | $616,000 | -41.6% | 16,123 | -38.5% | 0.03% | -49.2% |
Q3 2018 | $1,054,000 | -28.5% | 26,230 | -28.3% | 0.06% | 0.0% |
Q2 2018 | $1,474,000 | +127.5% | 36,572 | +120.3% | 0.06% | +85.7% |
Q1 2018 | $648,000 | -85.7% | 16,598 | -87.0% | 0.04% | -85.4% |
Q4 2017 | $4,517,000 | +1830.3% | 127,337 | +2190.2% | 0.24% | +895.8% |
Q1 2017 | $234,000 | +15.3% | 5,560 | +10.6% | 0.02% | -17.2% |
Q4 2015 | $203,000 | -95.1% | 5,025 | -93.9% | 0.03% | -92.6% |
Q2 2013 | $4,110,000 | – | 82,251 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |